Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Sanguina Raises $2.8M in Series A Funding to Drive Innovation in Home-Based Testing and Wellness Management
Life Sciences Times
-
July 25, 2023
0
Venture Capital
Spoke Sciences Acquires “SNAC” Drug Delivery Platform that Improves Bioavailability of Nutritional Supplements and Drugs
Life Sciences Times
-
July 25, 2023
0
Venture Capital
Quince Therapeutics to Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales...
Life Sciences Times
-
July 24, 2023
0
Venture Capital
SURGE Therapeutics Raises $32M Series B Financing to Advance Intraoperative Immunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery
Life Sciences Times
-
July 19, 2023
0
Venture Capital
KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million
Life Sciences Times
-
July 19, 2023
0
Venture Capital
Intel Capital and Khosla Ventures Lead $27M Investment in SiPhox® Health to Transform Health Testing
Life Sciences Times
-
July 19, 2023
0
Venture Capital
CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition
Life Sciences Times
-
July 14, 2023
0
Venture Capital
Korro Bio and Frequency Therapeutics Announce Merger Agreement
Life Sciences Times
-
July 14, 2023
0
Venture Capital
Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare
Life Sciences Times
-
July 13, 2023
0
Venture Capital
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Life Sciences Times
-
July 13, 2023
0
Venture Capital
Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery
Life Sciences Times
-
July 13, 2023
0
Venture Capital
Fortis Life Sciences acquires International Point of Care
Life Sciences Times
-
July 12, 2023
0
1
...
43
44
45
...
115
Page 44 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026